|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013089,
umls-concept:C0020823,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0035168,
umls-concept:C0086409,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C1257890,
umls-concept:C1261473,
umls-concept:C1705294,
umls-concept:C1707455
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-4-10
|
|
pubmed:abstractText |
To assess the progression-free survival (PFS) and antitumor response to standard-dose doxorubicin compared with sequential dose-dense doxorubicin and ifosfamide in first-line treatment of advanced soft tissue sarcoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AndrésRaquelR,
pubmed-author:BalañáCarmenC,
pubmed-author:BuesaJose MaríaJM,
pubmed-author:CasadoAntonioA,
pubmed-author:CruzJosefinaJ,
pubmed-author:CubedoRicardoR,
pubmed-author:Del MuroXavier GarcíaXG,
pubmed-author:FraJoaquínJ,
pubmed-author:GómezMaría AuxiliadoraMA,
pubmed-author:GallegoOscarO,
pubmed-author:López-PousaAntonioA,
pubmed-author:MartínJavierJ,
pubmed-author:Martínez-TruferoJavierJ,
pubmed-author:MaurelJoanJ,
pubmed-author:PovedaAndrésA,
pubmed-author:RubióJordiJ,
pubmed-author:Rubio-ViqueiraBelenB,
pubmed-author:SevillaIsabelI,
pubmed-author:de Las PeñasRamónR,
pubmed-author:de la CruzJuan JoseJJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1893-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19273704-Adolescent,
pubmed-meshheading:19273704-Adult,
pubmed-meshheading:19273704-Aged,
pubmed-meshheading:19273704-Antineoplastic Agents,
pubmed-meshheading:19273704-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19273704-Disease Progression,
pubmed-meshheading:19273704-Dose-Response Relationship, Drug,
pubmed-meshheading:19273704-Doxorubicin,
pubmed-meshheading:19273704-Female,
pubmed-meshheading:19273704-Humans,
pubmed-meshheading:19273704-Ifosfamide,
pubmed-meshheading:19273704-Male,
pubmed-meshheading:19273704-Middle Aged,
pubmed-meshheading:19273704-Remission Induction,
pubmed-meshheading:19273704-Sarcoma,
pubmed-meshheading:19273704-Soft Tissue Neoplasms,
pubmed-meshheading:19273704-Survival Analysis,
pubmed-meshheading:19273704-Treatment Outcome,
pubmed-meshheading:19273704-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
|
|
pubmed:affiliation |
Medical Oncology Department, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Hospital Clínic, Barcelona, Spain. jmaurel@clinic.ub.es
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
